Membranous nephropathy: new pathogenic mechanisms and their clinical implications

E Hoxha, L Reinhard, RAK Stahl - Nature Reviews Nephrology, 2022 - nature.com
Membranous nephropathy (MN) is characterized histomorphologically by the presence of
immune deposits in the subepithelial space of the glomerular filtration barrier; its clinical …

Evolving importance of kidney disease: from subspecialty to global health burden

KU Eckardt, J Coresh, O Devuyst, RJ Johnson… - The Lancet, 2013 - thelancet.com
In the past decade, kidney disease diagnosed with objective measures of kidney damage
and function has been recognised as a major public health burden. The population …

Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy

NM Tomas, LH Beck Jr… - … England Journal of …, 2014 - Mass Medical Soc
Background Idiopathic membranous nephropathy is an autoimmune disease. In
approximately 70% of patients, it is associated with autoantibodies against the …

A proposal for a serology-based approach to membranous nephropathy

AS De Vriese, RJ Glassock, KA Nath… - Journal of the …, 2017 - journals.lww.com
Primary membranous nephropathy (MN) is an autoimmune disease mainly caused by
autoantibodies against the recently discovered podocyte antigens: the M-type …

[HTML][HTML] Membranous nephropathy: integrating basic science into improved clinical management

DC Cattran, PE Brenchley - Kidney international, 2017 - Elsevier
Idiopathic membranous nephropathy (INM) remains a common cause of the nephrotic
syndrome in adults. The autoimmune nature of IMN was clearly delineated in 2009 with the …

An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain–containing 7A–specific antibodies in membranous nephropathy

E Hoxha, LH Beck Jr, T Wiech, NM Tomas… - Journal of the …, 2017 - journals.lww.com
Thrombospondin type 1 domain–containing 7A (THSD7A) is a target antigen identified in
adult membranous nephropathy (MN) along with the major antigen phospholipase A 2 …

[HTML][HTML] Complement C3a and C3a receptor activation mediates podocyte injuries in the mechanism of primary membranous nephropathy

S Gao, Z Cui, M Zhao - Journal of the American Society of …, 2022 - journals.lww.com
Background The complement system is highly activated in primary membranous
nephropathy (MN). Identifying the complement components that damage podocytes has …

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis

L Beck, AS Bomback, MJ Choi, LB Holzman… - American Journal of …, 2013 - Elsevier
Glomerulonephritis (GN) is an important cause of morbidity and mortality in patients of all
ages throughout the world. Because these disorders are relatively rare, it is difficult to …

[HTML][HTML] The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery

AE van de Logt, M Fresquet, JF Wetzels, P Brenchley - Kidney international, 2019 - Elsevier
The discovery in 2009 of the M-type phospholipase A2 receptor (PLA2R) as the primary
target in membranous nephropathy (MN) greatly advanced basic and clinical research …

[HTML][HTML] Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies

CP Larsen, NC Messias, FG Silva, E Messias… - Modern Pathology, 2013 - Elsevier
Autoantibody formation directed against phospholipase A2 receptor (PLA2R) 1 is the
underlying etiology in most cases of primary membranous glomerulopathy. This new …